1don MSN
BridgeBio Pharma eyes first treatment for rare muscle disorder as trial data shows early progress
BridgeBio Pharma Inc. BBIO on Wednesday announced a recent presentation of interim results from its Phase 3 FORTIFY trial for BBP-418, a treatment for limb-girdle muscular dystrophy type 2I/R9.
InvestorsHub on MSN
Precision BioSciences reports encouraging muscle improvements in preclinical DMD gene therapy study
Precision BioSciences Inc. (NASDAQ:DTIL) presented new preclinical findings for its PBGENE-DMD gene therapy at the Muscular ...
(CNN) — Protein shakes, pre-workout mixes and other supplements aren’t always just a part of a gym routine. In adolescents and young adults, they could be connected to a body image disorder that ...
Researchers have discovered a mechanism in our cells that is essential to energy production in the muscles. The discovery may lead to new treatment for disorders affecting the muscles, like diabetes, ...
People with spinal muscle atrophy (SMA), an inherited neuromuscular disease, usually experience muscle weakness that impacts movement. New research suggests that electrical spinal cord stimulation ...
Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results